Stay updated on Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.

Latest updates to the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page
- Check4 days agoChange DetectedA new site revision label v3.5.5 has been added, replacing the previous v3.5.4. This update reflects a minor platform release and does not modify the study content or user-facing information.SummaryDifference0.0%

- Check11 days agoChange DetectedDeleted sponsor/affiliate identifiers ('Moffitt Cancer Center Clinical Trials website' and 'H. Lee Moffitt Cancer Center and Research Institute') and the 'Helpful Links Provided by' heading, changing how institutional affiliation and sponsor-related resources are presented on the study page.SummaryDifference0.1%

- Check18 days agoChange DetectedA new Publications entry has been added, documenting a 2026 Am J Clin Oncol article evaluating neutrophil-to-lymphocyte ratio in patients treated with cetuximab and nivolumab for recurrent/metastatic head and neck squamous cell carcinoma.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page now displays a new site revision tag (Revision: v3.5.4) replacing the prior Revision: v3.5.3. This indicates a minor update to the page's template or underlying system, with no changes to the study content.SummaryDifference0.0%

- Check47 days agoChange DetectedThe footer revision number for the ClinicalTrials.gov page is updated from v3.5.2 to v3.5.3, reflecting a site software/release update rather than a change to the trial’s study details.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.